Minicircle Vector Production via Recombinase Segmentation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing minicircles for gene transfer and DNA vaccination face challenges such as low efficiency and biosafety concerns due to the dissemination of recombinant bacterial DNA, which can lead to uncontrolled spread of antibiotic resistance genes, and existing methods are expensive and difficult to scale up for industrial use.
Innovation Solution
A plasmid comprising a prokaryotic origin of replication, a marker sequence, two specific recombinase recognition sequences, and a multiple cloning site, with a gene coding for a sequence-specific recombinase, allowing for high-efficiency production of minicircles by ensuring controlled recombination and separation into miniplasmid and minicircle, optimizing bacterial culture conditions, and using specific recombinases like Cre or ParA resolvase.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If in vitro procedures (restriction digestion followed by ligation) are used to produce minicircle DNA, then precise control of minicircle structure is achieved, but the production cost increases dramatically and scaling up becomes extremely difficult
Solution Approach 1:
The patent replaces the in vitro mechanical enzymatic system (restriction digestion and ligation) with an in vivo biological system (bacterial recombination). By introducing a plasmid containing recombinase recognition sequences flanking the origin of replication and antibiotic resistance gene, and co-transforming with a recombinase-expressing plasmid, the system achieves minicircle production through bacterial recombination mechanisms rather than manual enzymatic processing, enabling scalable industrial production while maintaining structural precision
Solution Approach 2:
The patent implements self-service by designing the plasmid system to automatically produce minicircles through bacterial recombination without requiring manual intervention for each step. The recombinase enzyme, once expressed in the bacteria, automatically recognizes the recognition sequences and catalyzes the excision of the minicircle, eliminating the need for external enzymatic processing and enabling high-throughput production
2Productivity
If plasmid DNA with antibiotic resistance markers and bacterial origin of replication is used for gene transfer, then efficient bacterial propagation and selection are achieved, but biosafety risks increase due to potential environmental dissemination and horizontal gene transfer
Solution Approach 1:
The patent segments the plasmid DNA into two separate entities: a replicative miniplasmid containing the bacterial origin of replication and antibiotic resistance marker, and a non-replicative minicircle containing only the eukaryotic expression cassette. This segmentation allows the minicircle to be produced efficiently in bacteria while eliminating the risk of environmental dissemination, as the minicircle lacks the bacterial origin of replication and cannot replicate independently in the environment
Solution Approach 2:
The patent extracts the potentially harmful elements (bacterial origin of replication and antibiotic resistance marker) from the final minicircle product by placing them on a separate replicative miniplasmid. The minicircle is designed to contain only the essential eukaryotic expression cassette, thereby eliminating biosafety risks associated with environmental dissemination while maintaining the ability to produce large quantities in bacteria
3Productivity
If the original plasmid is transfected into bacteria recombinant for Cre recombinase, then minicircle production through site-specific recombination is achieved, but complete reconversion of plasmid DNA into minicircle DNA is difficult due to presence of unrecombined plasmid
Solution Approach 1:
The patent applies local quality by designing the plasmid with specific recombinase recognition sequences (loxP sites) flanking only the origin of replication and antibiotic resistance marker, while leaving the eukaryotic expression cassette intact. This localized recombination approach ensures that only the necessary portions are excised to form the minicircle, while the expression cassette remains on the minicircle for functional purposes, achieving both high production efficiency and complete recombination
Solution Approach 2:
The patent implements feedback through the use of density gradient centrifugation to separate supercoiled minicircle DNA from linear plasmid and miniplasmid DNA. The supercoiled conformation of successfully recombined minicircles provides a physical feedback mechanism that enables complete separation and purification, ensuring that only fully converted minicircle DNA is recovered in the final product
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach achieves near 100% minicircle production efficiency, improving gene transfer and bioavailability while addressing biosafety concerns by minimizing the spread of antibiotic resistance genes, and allows for scalable industrial production.
Implementation Method 1
a bacterium which is recombinant for the Cre recombinase, a bacteriophage P1 derived integrase catalysing site specific recombination between direct repeats of 34 base pairs (loxP sites)
Implementation Method 2
Undigested supercoiled minicircle can then density-separated from the linear original plasmid and excised miniplasmid on a cesium chloride gradient using the intercalating agent ethidium bromide
Data Source
AI summary
A plasmid is provided comprising the following functional units: a prokaryotic origin of replication, a marker sequence, two specific recombinase recognition sequences and a multiple cloning site, whereby it comprises a gene coding for a sequence specific recombinase, whereby the units are arranged on the plasmid in such a way that the plasmid is divided into a miniplasmid and a minicircle upon expression of the sequence specific recombinase, said miniplasmid comprising the prokaryotic origin of replication, the marker sequence and the gene for the sequence specific recombinase and said minicircle comprising the multiple cloning site.